| 1 |
35205737 | CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer. | 2022 Feb 16 |
2 |
| 2 |
33555529 | MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. | 2021 Feb |
1 |
| 3 |
34479917 | Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression. | 2021 Sep-Oct |
1 |
| 4 |
32395375 | Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers. | 2020 Apr |
1 |
| 5 |
31406477 | Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer. | 2019 |
1 |
| 6 |
30101722 | Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer. | 2018 |
1 |
| 7 |
23321641 | Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints. | 2013 Mar 1 |
1 |
| 8 |
21821547 | Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers. | 2012 Apr |
1 |
| 9 |
21822799 | Cdk2 acts upstream of mitochondrial permeability transition during paclitaxel-induced apoptosis. | 2011 Jul |
6 |
| 10 |
19239702 | Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells. | 2009 |
5 |
| 11 |
16020661 | Cyclin A-associated kinase activity is needed for paclitaxel sensitivity. | 2005 Jul |
4 |
| 12 |
15327838 | PEP8-TAT2, a membrane-permeable peptide, inhibits cyclin-Cdk2 activity in HeLa cells. | 2004 Sep 30 |
1 |